Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study

Add-on biological therapy has proven to be effective in many patients with severe eosinophilic asthma. In this observational multicenter retrospective study, we report the results obtained with mepolizumab and benralizumab in severe asthmatics treated for 12 months in a real-life setting. In these p...

Descripción completa

Detalles Bibliográficos
Autores principales: Maglio, Angelantonio, Vitale, Carolina, Pelaia, Corrado, D’Amato, Maria, Ciampo, Luigi, Sferra, Eliana, Molino, Antonio, Pelaia, Giulia, Vatrella, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916787/
https://www.ncbi.nlm.nih.gov/pubmed/36768778
http://dx.doi.org/10.3390/ijms24032455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916787/
https://www.ncbi.nlm.nih.gov/pubmed/36768778
http://dx.doi.org/10.3390/ijms24032455

Ejemplares similares